Benidipine hydrochloride structure
|
Common Name | Benidipine hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 91599-74-5 | Molecular Weight | 542.02 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 625.2±55.0 °C at 760 mmHg | |
| Molecular Formula | C28H32ClN3O6 | Melting Point | 199-201ºC | |
| MSDS | Chinese USA | Flash Point | 331.9±31.5 °C | |
| Symbol |
GHS06 |
Signal Word | Danger | |
Use of Benidipine hydrochlorideBenidipine hydrochloride is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension). |
| Name | 5-O-[(3R)-1-benzylpiperidin-3-yl] 3-O-methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate,hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | Benidipine hydrochloride is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension). |
|---|---|
| Related Catalog |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 625.2±55.0 °C at 760 mmHg |
| Melting Point | 199-201ºC |
| Molecular Formula | C28H32ClN3O6 |
| Molecular Weight | 542.02 |
| Flash Point | 331.9±31.5 °C |
| PSA | 124.28000 |
| LogP | 4.92 |
| Appearance of Characters | yellow |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.622 |
| InChIKey | KILKDKRQBYMKQX-MIPPOABVSA-N |
| SMILES | COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1.Cl |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
|
~37%
Benidipine hydr... CAS#:91599-74-5 |
| Literature: HEFEI BEINI MEDICAL TECHNOLOGY COMPANY, LTD; ZHANG, Zhaoyong Patent: WO2012/142815 A1, 2012 ; Location in patent: Page/Page column 5; 6 ; |
|
~%
Benidipine hydr... CAS#:91599-74-5 |
| Literature: Arzneimittel-Forschung/Drug Research, , vol. 38, # 11 A p. 1662 - 1665 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2942000000 |
|---|
|
Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease.
Int. J. Antimicrob. Agents 48 , 91-5, (2016) Despite current efforts worldwide to develop new medications against Chagas disease, only two drugs are available, nifurtimox and benznidazole. Both drugs require prolonged treatment and have multiple... |
| MFCD06797587 |
| (3R)-1-Benzylpiperidin-3-yl methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl (3R)-1-(phenylmethyl)-3-piperidinyl ester, (4R)- |
| methyl (3R)-1-(phenylmethyl)piperidin-3-yl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| (3R)-1-Benzyl-3-piperidinyl methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate |
| Coniel |
| (R*,R*)-(±)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid Methyl 1-(Phenylmethyl)-3-piperidinyl Ester |
| Benidipine |
| benipidine hydrochloride |
| ((+/-)-(R*)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate [(R*)-1-benzyl-3-piperidine alcohol ester]) hydrochloride |
| UNII:4G9T91JS7E |
| C28H31N3O6.HCl |
| Benidipene |
| (+-)-Benidipine hydrochloride |
| BENIDIPINE HCl |
| 5-O-methyl 3-O-[1-(phenylmethyl)-piperidin-3-yl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride |
| KW 3049 |
| 3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,methyl 1-(phenylmethyl)-3-piperidinyl ester,monohydrochloride,(R*,R*)-(+-) |
| 3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,methyl (3R)-1-(phenylmethyl)-3-piperidinyl ester,monohydrochloride,(4R)-rel |
| EINECS 1592732-453-0 |
| Benidipine (hydrochloride) |